Arie Belldegrun - Director at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ALLO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Arie Belldegrun - trading volume in the past year for Allogene Therapeutics, Inc.

Holdings reported by Arie Belldegrun for Allogene Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 1,866,859 $5.41 M $2.90 May 16, 2024 Direct
Common Stock 1,724,137 $5 M $2.90 May 16, 2024 Indirect
Stock Option (Right to buy) 749,398 Jan 25, 2024 Direct Common Stock

Transactions reported by Arie Belldegrun for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership